corporate overview
research & development
products
technical overview
competitive advantage
management group
contact us
home
   
 



Juvaris Technology Advantages

Potent induction of specific immunity (cellular & humoral) and innate immunity (cytokines, NK cells)
Superior activation of CD8+ CTL-mediated responses
Rapid, efficient, simple vaccine formulation
Use of unmodified immunogens (proteins, peptides or mixtures)
Stability in lyophilized form
Administration by oral, inhalation, sc, ip, iv routes
Broad-based disease applicability

 


Adjuvant provides immune stimulation at least ten-fold greater than field

System offers substantial advantages over oligonucleotide-based immunotherapeutics, including:
     simplicity of construction and formulation
     reduced cost of production
     high dose efficiency and potency
     broad activity in multiple species by a variety of routes

 


Tests in mice and dogs with naturally occurring tumors demonstrate that JuvaVaxTM is a potent therapeutic cancer vaccine

JuvaVaxTM provides a more powerful therapeutic vaccine for cancer and infectious diseases than conventional vaccines

JuvaVaxTM functionally active in an immunocompromised mouse model suggesting application in patients with disease